WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'0201 Infant (under 12 months) mortality rate: 242
GDP / capita (US$): 7'3791 Child (under 5 years) mortality rate: 282

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 34'378  33'921  33'453  32'984  32'532  28'951  24'950  20'072 
Births 699  703  703  700  693  624  734  763 
Surviving infants 683  686  685  681  674  598  690  692 
Pop. less than 5 years 3'421  3'393  3'350  3'289  3'212  3'094  3'426  3'200 
Pop. less than 15 years 9'358  9'270  9'184  9'110  9'054  9'718  9'896  8'701 
Female 15-49 years 9'364  9'309  9'245  9'172  9'092  7'796  5'976  4'590 

Number of reported cases

(Click for retrospective incidence data for Morocco)
Diphtheria
ChartChart
  43 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  17  10  92  668  982  7'368  1'577  86'919 
Mumps
ChartChart
 
Pertussis
ChartChart
  72  172  35  22  83  14'873 
Polio*
ChartChart
  52 
Rubella
ChartChart
  59 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  28 
Tetanus (total)**
ChartChart
  23  69  16  73  81 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Morocco)
Vaccine year result method % card seen                                                
BCG          99*  99*  99*  99*  99*  97  96 
DTP1          99*  99*  99*  99*  99*  98 
DTP3          99  99  99  99  99  95  81 
DTP4          97  92 
IPV1          80 
HepB_BD          99*  99*  99*  99*  99*  10 
HepB3          99  99  99  99*  98  43 
Hib3          99  99  99  99  98 
JapEnc         
MCV1          99*  99  99  99  99*  93  79 
MCV2          95  95  10 
PCV1          97  99  99  86  91 
PCV3          95  80  80  72  23 
Pol3          99  99  99  99  98  95  81 
Rota1          97  95  95  91  87 
RotaC          90  90  90  88  80 
Rubella1          99* 
TT2plus 1994  54  DHS   51  90  64 
PAB         
VAD1          90  98  98  80  80  40 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Morocco)
BCG
ChartChart
  99  99  99  99  99  97  96 
DTP1
ChartChart
  99  99  99  99  99  98  93 
DTP3
ChartChart
  99  99  99  99  99  95  81 
HepB3
ChartChart
  99  99  99  99  98  43 
HepB_BD
ChartChart
  14  14  14 
Hib3
ChartChart
  99  99  99  99  99 
IPV1
ChartChart
  33 
MCV1
ChartChart
  99  99  99  99  99  93  79 
MCV2
ChartChart
  95  54 
PAB
ChartChart
  88  88  89  89  89  86  66 
PCV3
ChartChart
  95  80  80  72  23 
Pol3
ChartChart
  99  99  99  99  98  95  81 
RCV1
ChartChart
  99  99 
RotaC
ChartChart
  90  90  90  88  80 

Number of districts in the country 81  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 98
From 80 to 89% 2
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 month; Yes
DTwP 18 months; 5 years; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB birth; Yes and health care workers
IPV 4 months; Yes
MR 9, 18 months; Yes
Measles 18 months; Yes
OPV 1, 2, 3, 4, 18 months; 5 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Rotavirus 2, 3, 4 months; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number     2008-2012  2008-2012  2008-2012  2010-2012  2009-20011 
Nº of districts with microplans that include activities to raise immunization coverage number 81  81  81  81  68  68  68 

System performance

Total Nº districts in country number 81  81  81  81  68  68  68 
Nº districts with DTP3 coverage >=80% number 81  81  80  79  68  68  67 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  99  98  100  100  99 
Nº districts with measles (MCV1) coverage >=95% number 50  51  65  47  45  39  32 
% of districts with MCV1 coverage >=95% From 0 to 100% 62  63  80  58  66  57  47 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%         101  100  80 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.